I'm happy to take that.
Stem Cell Network is about following the research and supporting it as it develops. Clinical trials are a key piece of work that the Stem Cell Network invests in. We fund early phase I and phase II clinical trials. We support companies through research projects to ensure that those companies that are at the preclinical or clinical stage can develop the data, validation materials and packages they need to bring investors in on their projects. This is absolutely critical at the translational space. It's not widely done by organizations or networks like ours, and it's absolutely essential for moving research forward.
In fact, two of our projects and programs that we have been working on over the years on type 1 diabetes and premature infants with underdeveloped lungs will now be launching into clinical trials in December. These will be world firsts for Canada.
That's how we're moving things forward.